Stem from WHO's stem book, 2024; description by Arca
Stem -fusp
Class Proteins made by joining pieces of different proteins in one chain Approved and clinical-stage drugs in ChEMBL whose names ending in -fusp, matched by spelling; those with a US drug page link to it. Drug Furthest stage Acts on Mechanism Tagraxofusp Approved IL3RA , EEF2 Interleukin-3 receptor subunit alpha binding agent Tebentafusp Approved PMEL Melanocyte protein PMEL binding agent Tividenofusp alfa Phase 2 — — Bintrafusp alfa Phase 3 CD274 , Transforming growth factor beta Programmed cell death 1 ligand 1 binding agent Brenetafusp Phase 3 — — Onfekafusp alfa Phase 3 — — Pabinafusp alfa Phase 3 Dermatan sulfate , TFR2, TFRC , Heparan sulfate Dermatan sulfate hydrolytic enzyme Retlirafusp alfa Phase 3 — — Amtabafusp alfa Phase 2 — — Amulirafusp alfa Phase 2 — — Bizaxofusp Phase 2 — — Cemavafusp Phase 2 — — Cinrebafusp alfa Phase 2 — — Efdelikofusp alfa Phase 2 — — Efzilonkofusp alfa Phase 2 — — Etakafusp alfa Phase 2 — — Invikafusp alfa Phase 2 — — Latikafusp Phase 2 — — Lunaxafusp Phase 2 — — Nanrilkefusp alfa Phase 2 — — Nomlabofusp Phase 2 — — Palverafusp alfa Phase 2 — — Rasdegafusp alfa Phase 2 LY75 , CTAG1A, CTAG1B Lymphocyte antigen 75 binding agent Rozibafusp alfa Phase 2 ICOS , TNFSF13B Inducible T-cell costimulator inhibitor Solabafusp alfa Phase 2 — — Sotiburafusp alfa Phase 2 — — Vensobafusp alfa Phase 2 — — Vimekofusp Phase 2 — — Vislarafusp alfa Phase 2 — — Clervonafusp alfa Phase 1 — — Dalutrafusp alfa Phase 1 — — Eciskafusp alfa Phase 1 — — Englumafusp alfa Phase 1 — — Ficerafusp alfa Phase 1 — — Lucorafusp alfa Phase 1 — — Modakafusp alfa Phase 1 — — Simlukafusp alfa Phase 1 IL2RB, IL2RG , FAP IL-2R beta/gamma binding agent Valanafusp alfa Phase 1 — —
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO
Run trial data against your own protocol Arca reads registry records alongside your protocol and study documents, and cites every claim to its source.
Our team comes from